Lingzhen Wang

Lingzhen Wang

Auto-generated profile, based on publicly available information

Lingzhen Wang

Department of Pediatrics Affiliated Hospital of Qingdao University Qingdao China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2022 in Water Supply
Verified
Journal Article
Open access
PDF file
LZLei Zhang
Lei Zhang
QZQian Zheng
Qian Zheng
LWLingzhen Wang
Lingzhen Wang
PJPengkang Jin
Pengkang Jin
Shengjiong YangShengjiong Yang
Shengjiong Yang
Fe2+ is widely used for effective peroxymonosulfate (PMS) activation to eliminate refractory organics. However, Fe2+/PMS process suffers from difficulty on Fe2+ regeneration. Herein, we report an Fe3+/PMS process by using gallic acid (GA) as an effective promotor for efficient degradation of bisphenol A (BPA). The process exhibited considerable oxidation performance in the pH range of 3.0–10.0. Higher concentration of Fe3+/GA complex exhibited better BPA degradation performance whereby BPA could be completely degraded within 4 mins. Reactive oxidation species (ROS) quenching experiments, electron paramagnetic resonance (EPR) analysis, and methyl phenyl sulfoxide (PMSO) probing experiments revealed that sulfate radical (SO4•−), hydroxyl radical (HO•), and ferryl species are involved and responsible for the BPA degradation. Electrochemical analysis and density function theory (DFT) calculation explored that the self-oxidation of GA boosted the reduction of Fe3+ into Fe2+ for continuous activation of PMS. The GA boosted Fe3+/PMS system reached an intriguing mineralization efficiency of 86.4%. Findings from this work proposed references to improve the oxidation performance of Fenton-like reaction and provided new sight into the Fe3+/Fe2+ cycling.

12 March 2025 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
FYFeiyu Yan
Feiyu Yan
SWShengnan Wang
Shengnan Wang
YWYilin Wang
Yilin Wang
YSYan Sun
Yan Sun
JYJing Yang
Jing Yang
LWLingzhen Wang
Lingzhen Wang
Background: Acute lymphoblastic leukemia (ALL) is a prevalent hematologic malignancy that primarily affects children. The diagnosis and treatment of pediatric ALL remain challenging. This study aimed to identify differential lipids and metabolites that may hold potential for improving ALL treatment. Methods: In this retrospective case-control study, serum samples obtained from children with ALL and healthy controls were analyzed. Serum lipidome and metabolome alterations of ALL were analyzed by comparing pediatric patients with ALL with healthy controls based on liquid chromatography high-resolution mass spectrometry analysis of serum lipidomic and metabolomic signatures. Results: We identified 2,298 lipid features in the serum. Among them, 72 (3.13%) differed significantly in pediatric patients with ALL compared to healthy controls. Notably, sphingolipids (ceramide and sphingomyelin) and phospholipids exhibited the most pronounced changes. Targeted analysis of ceramides revealed significantly elevated levels of Cer 18:0 and Cer 20:0 in the serum of pediatric patients with ALL. Additionally, gut microbial-related lipids (such as sulfonolipids and fatty acid esters of hydroxy fatty acids) showed significant alterations. Metabolomic analysis identified 15 differential metabolites, indicating disrupted nucleotide and amino acid metabolism. Furthermore, the dysregulated lipids and metabolites correlated with various blood indicators, with ceramide and nucleosides positively associated with white blood cell count but negatively correlated with hemoglobin and platelet. Conclusion: These findings shed light on abnormal molecular signatures contributing to pediatric ALL and may serve as potential biomarker panel for therapy of ALL.

21 August 2025 in Cancer Medicine
Verified
Journal Article
Open access
WGWenting Gan
Wenting Gan
WZWeina Zhang
Weina Zhang
JCJiaoyang Cai
Jiaoyang Cai
XZXiaofan Zhu
Xiaofan Zhu
JYJie Yu
Jie Yu
LWLingzhen Wang
Lingzhen Wang
Objective: Acute abdomen presents a significant challenge in the treatment of childhood acute lymphoblastic leukemia (ALL), potentially leading to treatment failure and treatment‐related mortality. Results from the multicenter study of CCCG‐ALL‐2015 showed significant improvements in overall survival (OS) and event‐free survival (EFS) for childhood ALL. However, the primary aim of this study was to determine the incidence, risk factors, and clinical impact of acute abdomen in the CCCG‐ALL‐2015 protocol, with the ultimate goal in the future of establishing evidence‐based preventive strategies to reduce its occurrence.Methods: Patients participating in the CCCG‐ALL‐2015 protocol from January 1, 2015, to December 31, 2019, were included in this analysis. The occurrence of acute abdomen in 7640 patients with ALL was analyzed retrospectively. The data was collected in August 2023 from the Data Center. Acute abdomen analyzed in this study included: acute pancreatitis, acute appendicitis, ileus, enterobrosis, enterorrhagia, peritonitis, enteritis, and others (urinary calculus, anaphylactoid purpura, cholecystitis). The clinical data of patients with acute abdomen were extracted from the database and analyzed.Results: A total of 7640 patients were recruited in the study, and 512 (6.7%) patients diagnosed with acute abdomen were identified. Of the 512 patients, 50 patients experienced two episodes of acute abdomen, 5 patients had three episodes, and 2 patients had four episodes. Among different types of acute abdomen, the incidence of acute pancreatitis was the highest (4.0%), followed by ileus (1.2%) and acute appendicitis (0.7%). There was no difference in the incidence of acute abdomen between males and females (6.6% vs. 6.9%, p = 0.64). The incidence of acute abdomen was associated with age, and patients older than 10 years had a significantly higher incidence rate than those less than 1 year and 1–10 years old (13.0% vs. 5.7%, p < 0.0001). The incidence rate of enterorrhagia was significantly higher in patients less than 1 year and older than 10 years than that in patients aged 1–10 years old (1.4% vs. 0.4%, p < 0.0001). The incidence of acute abdomen in the intermediate or high‐risk (I/HR) group was higher than that in the low‐risk (LR) group (9.9% vs. 3.7%, p < 0.001). Acute abdomen mainly occurred in the induction remission phase (57.3%) and the continuation and reinduction phase (39.3%). A total of 16 patients died from acute abdomen, including four patients in the LR group and 12 patients in the I/HR group. Among the different types of acute abdomen, the mortality rate of enterorrhagia was the highest (16.7%), followed by enterobrosis (9.1%).Conclusion: This multicenter study investigates the frequency, risk factors, and impact of acute abdomen in the CCCG‐ALL‐2015 protocol, the largest pediatric ALL study in China. We identified acute abdomen in 6.7% of patients, with the highest incidence during the induction remission phase and in older children and those with intermediate or high‐risk ALL. Acute pancreatitis was the most common type, while enterorrhagia had the highest mortality. These findings underscore the need for heightened vigilance and proactive management of acute abdomen to improve outcomes in children with ALL.Trial Registration: Chinese Clinical Trial Registry: ChiCTR‐IPR‐14005706

14 April 2024
Verified
Journal Article
Open access
YSY Sun
Y Sun
JJJ Jiang
J Jiang
LSL R Sun
L R Sun
FYF Y Yan
F Y Yan
LWL Z Wang
L Z Wang